Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 153 | 2024 | 3047 | 12.800 |
Why?
|
Pulmonary Emphysema | 29 | 2024 | 672 | 4.370 |
Why?
|
Forced Expiratory Volume | 38 | 2023 | 1744 | 2.610 |
Why?
|
alpha 1-Antitrypsin Deficiency | 11 | 2022 | 107 | 2.390 |
Why?
|
Emphysema | 14 | 2024 | 247 | 1.900 |
Why?
|
Genetic Predisposition to Disease | 69 | 2023 | 17449 | 1.710 |
Why?
|
Smoking | 54 | 2023 | 8986 | 1.670 |
Why?
|
Idiopathic Pulmonary Fibrosis | 5 | 2023 | 451 | 1.600 |
Why?
|
alpha 1-Antitrypsin | 10 | 2022 | 164 | 1.400 |
Why?
|
Lung | 40 | 2023 | 9852 | 1.370 |
Why?
|
Genome-Wide Association Study | 49 | 2023 | 12264 | 1.350 |
Why?
|
Asthma | 19 | 2023 | 6011 | 1.210 |
Why?
|
Gene Expression Profiling | 12 | 2024 | 9438 | 0.930 |
Why?
|
Polymorphism, Single Nucleotide | 49 | 2023 | 15525 | 0.910 |
Why?
|
Genetic Linkage | 8 | 2014 | 2422 | 0.900 |
Why?
|
Pulmonary Medicine | 2 | 2019 | 213 | 0.820 |
Why?
|
Gene Regulatory Networks | 8 | 2023 | 1708 | 0.820 |
Why?
|
Sequence Analysis, RNA | 6 | 2022 | 2013 | 0.790 |
Why?
|
Respiration Disorders | 2 | 2022 | 371 | 0.780 |
Why?
|
Pharmacogenetics | 2 | 2019 | 676 | 0.770 |
Why?
|
Phenotype | 36 | 2022 | 16365 | 0.730 |
Why?
|
Bronchodilator Agents | 10 | 2021 | 502 | 0.730 |
Why?
|
Pulmonary Eosinophilia | 1 | 2019 | 82 | 0.670 |
Why?
|
Sputum | 2 | 2019 | 476 | 0.660 |
Why?
|
Vital Capacity | 13 | 2023 | 926 | 0.640 |
Why?
|
Sleep Medicine Specialty | 1 | 2019 | 71 | 0.630 |
Why?
|
Genetic Loci | 7 | 2019 | 2575 | 0.620 |
Why?
|
Respiratory Function Tests | 17 | 2023 | 1618 | 0.600 |
Why?
|
Spirometry | 19 | 2023 | 864 | 0.600 |
Why?
|
Epoxide Hydrolases | 6 | 2010 | 122 | 0.580 |
Why?
|
Eosinophils | 2 | 2018 | 956 | 0.580 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 572 | 0.570 |
Why?
|
Quantitative Trait Loci | 11 | 2023 | 2019 | 0.570 |
Why?
|
Macrophages, Alveolar | 1 | 2019 | 407 | 0.570 |
Why?
|
Gene Expression | 7 | 2021 | 7799 | 0.570 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 5 | 2021 | 104 | 0.560 |
Why?
|
Respiratory Mucosa | 2 | 2019 | 427 | 0.550 |
Why?
|
Gene Expression Regulation | 15 | 2023 | 12075 | 0.550 |
Why?
|
Middle Aged | 117 | 2023 | 213367 | 0.550 |
Why?
|
Pulmonary Diffusing Capacity | 4 | 2023 | 88 | 0.540 |
Why?
|
Bronchitis, Chronic | 4 | 2022 | 62 | 0.540 |
Why?
|
Tomography, X-Ray Computed | 29 | 2022 | 20123 | 0.540 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3598 | 0.530 |
Why?
|
Genotype | 23 | 2023 | 12956 | 0.530 |
Why?
|
Adrenal Cortex Hormones | 4 | 2021 | 1854 | 0.530 |
Why?
|
Pulmonary Surfactant-Associated Protein B | 5 | 2008 | 42 | 0.520 |
Why?
|
Humans | 188 | 2024 | 744220 | 0.520 |
Why?
|
Aged | 94 | 2023 | 163253 | 0.490 |
Why?
|
Glutathione S-Transferase pi | 3 | 2013 | 97 | 0.490 |
Why?
|
Disease Progression | 18 | 2023 | 13280 | 0.480 |
Why?
|
Genetic Markers | 9 | 2022 | 2634 | 0.480 |
Why?
|
Incidental Findings | 1 | 2019 | 689 | 0.470 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4477 | 0.440 |
Why?
|
Male | 120 | 2023 | 350027 | 0.440 |
Why?
|
Hepatitis C | 1 | 2023 | 1591 | 0.430 |
Why?
|
Female | 121 | 2023 | 380197 | 0.420 |
Why?
|
Computational Biology | 5 | 2021 | 3523 | 0.410 |
Why?
|
Severity of Illness Index | 24 | 2023 | 15538 | 0.400 |
Why?
|
SOXD Transcription Factors | 1 | 2011 | 47 | 0.390 |
Why?
|
Exercise Tolerance | 5 | 2023 | 770 | 0.360 |
Why?
|
Cachexia | 3 | 2020 | 204 | 0.340 |
Why?
|
Oxygen | 2 | 2018 | 4187 | 0.340 |
Why?
|
Heterozygote | 6 | 2022 | 2805 | 0.340 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2010 | 326 | 0.340 |
Why?
|
Respiratory Mechanics | 1 | 2013 | 686 | 0.330 |
Why?
|
Genetic Variation | 10 | 2021 | 6546 | 0.330 |
Why?
|
Case-Control Studies | 26 | 2022 | 21752 | 0.320 |
Why?
|
Activin Receptors, Type I | 2 | 2019 | 142 | 0.310 |
Why?
|
Indians, Central American | 1 | 2007 | 15 | 0.310 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 367 | 0.310 |
Why?
|
Genome, Human | 5 | 2018 | 4420 | 0.310 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2009 | 314 | 0.300 |
Why?
|
Sepsis | 1 | 2021 | 2593 | 0.300 |
Why?
|
DNA Methylation | 5 | 2023 | 4289 | 0.300 |
Why?
|
Aged, 80 and over | 34 | 2022 | 57768 | 0.300 |
Why?
|
beta-Defensins | 1 | 2006 | 57 | 0.290 |
Why?
|
Scavenger Receptors, Class A | 1 | 2006 | 54 | 0.290 |
Why?
|
Muscarinic Antagonists | 2 | 2018 | 137 | 0.280 |
Why?
|
Critical Care | 1 | 2019 | 2644 | 0.270 |
Why?
|
Iron Regulatory Protein 2 | 3 | 2015 | 41 | 0.270 |
Why?
|
Genetic Testing | 1 | 2019 | 3443 | 0.270 |
Why?
|
Longitudinal Studies | 18 | 2023 | 13990 | 0.270 |
Why?
|
Cluster Analysis | 7 | 2023 | 2715 | 0.260 |
Why?
|
Proteoglycans | 1 | 2009 | 835 | 0.260 |
Why?
|
Linkage Disequilibrium | 7 | 2017 | 1997 | 0.260 |
Why?
|
Genomics | 6 | 2018 | 5722 | 0.250 |
Why?
|
Proteomics | 6 | 2024 | 3637 | 0.250 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2006 | 462 | 0.250 |
Why?
|
DNA Helicases | 1 | 2010 | 861 | 0.250 |
Why?
|
Membrane Glycoproteins | 5 | 2021 | 3769 | 0.240 |
Why?
|
Polyadenylation | 2 | 2021 | 117 | 0.240 |
Why?
|
Quantitative Trait, Heritable | 1 | 2006 | 544 | 0.230 |
Why?
|
Molecular Epidemiology | 3 | 2020 | 468 | 0.230 |
Why?
|
RNA | 3 | 2023 | 2749 | 0.230 |
Why?
|
Cohort Studies | 25 | 2022 | 40559 | 0.230 |
Why?
|
Niacin | 1 | 2023 | 116 | 0.220 |
Why?
|
Respiratory Physiological Phenomena | 2 | 2023 | 188 | 0.220 |
Why?
|
Mucin-5B | 1 | 2023 | 141 | 0.210 |
Why?
|
Risk Factors | 32 | 2022 | 72280 | 0.210 |
Why?
|
RNA Splice Sites | 1 | 2023 | 209 | 0.210 |
Why?
|
Exons | 5 | 2023 | 2439 | 0.210 |
Why?
|
Thoracoscopy | 1 | 2003 | 178 | 0.210 |
Why?
|
Somatomedins | 1 | 2022 | 192 | 0.210 |
Why?
|
Polymorphism, Genetic | 6 | 2013 | 4328 | 0.210 |
Why?
|
Carrier Proteins | 5 | 2021 | 5021 | 0.210 |
Why?
|
Administration, Inhalation | 3 | 2021 | 1104 | 0.200 |
Why?
|
Genes, Overlapping | 1 | 2021 | 36 | 0.200 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 2 | 2012 | 49 | 0.200 |
Why?
|
Transforming Growth Factor beta1 | 3 | 2019 | 644 | 0.200 |
Why?
|
HLA-A2 Antigen | 1 | 2021 | 213 | 0.190 |
Why?
|
Albuterol | 2 | 2014 | 208 | 0.190 |
Why?
|
Models, Genetic | 4 | 2017 | 3494 | 0.190 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2010 | 1221 | 0.190 |
Why?
|
Desmoplakins | 1 | 2020 | 62 | 0.190 |
Why?
|
Serpin E2 | 4 | 2020 | 48 | 0.190 |
Why?
|
Status Asthmaticus | 1 | 2020 | 22 | 0.190 |
Why?
|
Pneumonectomy | 1 | 2007 | 1094 | 0.190 |
Why?
|
Protective Agents | 1 | 2021 | 156 | 0.180 |
Why?
|
Genetic Association Studies | 4 | 2018 | 2702 | 0.180 |
Why?
|
Receptors, Nicotinic | 3 | 2015 | 497 | 0.180 |
Why?
|
Follow-Up Studies | 13 | 2021 | 39045 | 0.180 |
Why?
|
Pleural Effusion | 1 | 2003 | 338 | 0.180 |
Why?
|
Databases, Genetic | 3 | 2019 | 1782 | 0.180 |
Why?
|
Risk Assessment | 9 | 2022 | 23337 | 0.170 |
Why?
|
Models, Statistical | 3 | 2021 | 5102 | 0.170 |
Why?
|
Body Mass Index | 7 | 2019 | 12718 | 0.170 |
Why?
|
Citrullus | 1 | 2018 | 4 | 0.170 |
Why?
|
Chromosomes, Human, Pair 15 | 3 | 2015 | 374 | 0.170 |
Why?
|
Hemolysis | 1 | 2021 | 420 | 0.170 |
Why?
|
Algorithms | 7 | 2023 | 13885 | 0.170 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2019 | 75 | 0.170 |
Why?
|
Linear Models | 7 | 2020 | 5953 | 0.170 |
Why?
|
Adult | 35 | 2023 | 214035 | 0.170 |
Why?
|
Costa Rica | 3 | 2007 | 177 | 0.170 |
Why?
|
Meta-Analysis as Topic | 2 | 2021 | 1344 | 0.160 |
Why?
|
Chromosome Mapping | 5 | 2018 | 4742 | 0.160 |
Why?
|
Comorbidity | 6 | 2016 | 10387 | 0.160 |
Why?
|
RNA Splicing | 1 | 2023 | 907 | 0.160 |
Why?
|
Lung Neoplasms | 3 | 2019 | 13096 | 0.160 |
Why?
|
Interferons | 1 | 2022 | 706 | 0.160 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2018 | 33 | 0.160 |
Why?
|
Heme | 1 | 2020 | 307 | 0.160 |
Why?
|
Alternative Splicing | 2 | 2023 | 1118 | 0.160 |
Why?
|
Oligonucleotides | 1 | 2021 | 572 | 0.160 |
Why?
|
Plant Diseases | 1 | 2018 | 150 | 0.150 |
Why?
|
Leukocyte Count | 2 | 2018 | 1584 | 0.150 |
Why?
|
Adolescent Development | 1 | 2021 | 278 | 0.150 |
Why?
|
F-Box Proteins | 1 | 2019 | 197 | 0.150 |
Why?
|
Immunoglobulin E | 2 | 2021 | 1463 | 0.150 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1043 | 0.150 |
Why?
|
Sarcopenia | 1 | 2022 | 368 | 0.150 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2021 | 306 | 0.150 |
Why?
|
Xenobiotics | 1 | 2017 | 73 | 0.150 |
Why?
|
Hypersensitivity, Immediate | 1 | 2020 | 337 | 0.150 |
Why?
|
Age of Onset | 5 | 2017 | 3270 | 0.150 |
Why?
|
Serine Proteinase Inhibitors | 2 | 2011 | 179 | 0.150 |
Why?
|
Radiography, Thoracic | 2 | 2014 | 1265 | 0.150 |
Why?
|
DNA | 2 | 2010 | 7303 | 0.140 |
Why?
|
Enhancer Elements, Genetic | 2 | 2014 | 1341 | 0.140 |
Why?
|
HIV Infections | 1 | 2023 | 16718 | 0.140 |
Why?
|
Plant Proteins | 1 | 2018 | 364 | 0.140 |
Why?
|
rac GTP-Binding Proteins | 1 | 2017 | 164 | 0.140 |
Why?
|
Software | 3 | 2020 | 4442 | 0.140 |
Why?
|
Carbon Monoxide | 1 | 2019 | 531 | 0.140 |
Why?
|
United States | 18 | 2021 | 69867 | 0.140 |
Why?
|
C-Reactive Protein | 2 | 2012 | 3778 | 0.140 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5755 | 0.140 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4803 | 0.130 |
Why?
|
Signal Transduction | 3 | 2019 | 23404 | 0.130 |
Why?
|
Metabolomics | 2 | 2021 | 1483 | 0.130 |
Why?
|
Galactosylceramidase | 1 | 2015 | 19 | 0.130 |
Why?
|
Hepacivirus | 1 | 2023 | 1379 | 0.130 |
Why?
|
Cadherins | 2 | 2017 | 907 | 0.130 |
Why?
|
Smoking Cessation | 3 | 2020 | 2071 | 0.130 |
Why?
|
Prospective Studies | 13 | 2023 | 53280 | 0.130 |
Why?
|
Axonemal Dyneins | 1 | 2014 | 24 | 0.130 |
Why?
|
Surgery, Computer-Assisted | 1 | 2003 | 1018 | 0.130 |
Why?
|
Dermatitis, Atopic | 1 | 2021 | 654 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1782 | 0.120 |
Why?
|
Metformin | 1 | 2021 | 835 | 0.120 |
Why?
|
Adrenergic beta-Agonists | 1 | 2016 | 346 | 0.120 |
Why?
|
Pneumonia | 2 | 2017 | 2134 | 0.120 |
Why?
|
RNA, Viral | 1 | 2023 | 2902 | 0.120 |
Why?
|
Dyspnea | 4 | 2023 | 1303 | 0.120 |
Why?
|
Quality of Life | 11 | 2023 | 12805 | 0.120 |
Why?
|
Fibroblasts | 3 | 2021 | 4156 | 0.120 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 808 | 0.120 |
Why?
|
Glutathione Transferase | 2 | 2013 | 595 | 0.120 |
Why?
|
RNA, Untranslated | 1 | 2017 | 454 | 0.120 |
Why?
|
Alleles | 7 | 2017 | 6938 | 0.120 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2010 | 1121 | 0.120 |
Why?
|
Pectoralis Muscles | 1 | 2014 | 82 | 0.120 |
Why?
|
Protease Nexins | 2 | 2010 | 40 | 0.120 |
Why?
|
Rest | 3 | 2016 | 901 | 0.120 |
Why?
|
Cystic Fibrosis | 1 | 2022 | 1178 | 0.110 |
Why?
|
Lymphocytes | 1 | 2021 | 2617 | 0.110 |
Why?
|
Nerve Tissue Proteins | 4 | 2021 | 4465 | 0.110 |
Why?
|
Pedigree | 4 | 2009 | 4648 | 0.110 |
Why?
|
Chemokines | 1 | 2017 | 969 | 0.110 |
Why?
|
Osteoporosis | 1 | 2022 | 1580 | 0.110 |
Why?
|
Gene Frequency | 4 | 2021 | 3588 | 0.110 |
Why?
|
Uteroglobin | 1 | 2012 | 58 | 0.110 |
Why?
|
Radiology | 1 | 2007 | 2099 | 0.110 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.110 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 782 | 0.110 |
Why?
|
Multivariate Analysis | 8 | 2020 | 12244 | 0.110 |
Why?
|
Cytokines | 2 | 2017 | 7326 | 0.110 |
Why?
|
RNA-Binding Proteins | 2 | 2020 | 1903 | 0.110 |
Why?
|
Chromosomes, Human | 1 | 2014 | 457 | 0.100 |
Why?
|
Lung Volume Measurements | 1 | 2013 | 378 | 0.100 |
Why?
|
Predictive Value of Tests | 5 | 2022 | 15070 | 0.100 |
Why?
|
North America | 3 | 2015 | 1250 | 0.100 |
Why?
|
Infant, Premature | 1 | 2021 | 2044 | 0.100 |
Why?
|
Blood Proteins | 1 | 2016 | 1123 | 0.100 |
Why?
|
Transcription Factors | 3 | 2022 | 12207 | 0.100 |
Why?
|
Disease Management | 2 | 2020 | 2458 | 0.100 |
Why?
|
Lod Score | 2 | 2009 | 615 | 0.100 |
Why?
|
Pneumothorax | 1 | 2014 | 379 | 0.100 |
Why?
|
Chromosomes, Human, Pair 4 | 4 | 2015 | 374 | 0.100 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18027 | 0.090 |
Why?
|
Superoxide Dismutase | 2 | 2010 | 596 | 0.090 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2011 | 367 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2020 | 1343 | 0.090 |
Why?
|
Norway | 4 | 2014 | 448 | 0.090 |
Why?
|
Pulmonary Alveoli | 1 | 2013 | 675 | 0.090 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2009 | 49 | 0.090 |
Why?
|
Consensus | 1 | 2019 | 2958 | 0.090 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9647 | 0.090 |
Why?
|
Receptors, Cell Surface | 2 | 2010 | 2867 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4188 | 0.090 |
Why?
|
Cross-Sectional Studies | 9 | 2020 | 25043 | 0.090 |
Why?
|
Prognosis | 7 | 2023 | 29050 | 0.090 |
Why?
|
Child Development | 1 | 2021 | 2223 | 0.090 |
Why?
|
Logistic Models | 7 | 2019 | 13409 | 0.080 |
Why?
|
Europe | 4 | 2019 | 3339 | 0.080 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 1199 | 0.080 |
Why?
|
Survival Analysis | 5 | 2022 | 10250 | 0.080 |
Why?
|
Premature Birth | 1 | 2021 | 1721 | 0.080 |
Why?
|
Respiratory Tract Diseases | 1 | 2014 | 722 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2018 | 2108 | 0.080 |
Why?
|
Sensitivity and Specificity | 4 | 2017 | 14726 | 0.080 |
Why?
|
Penetrance | 2 | 2023 | 381 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2017 | 989 | 0.080 |
Why?
|
Respiratory System | 2 | 2015 | 557 | 0.080 |
Why?
|
Inflammation | 4 | 2023 | 10634 | 0.080 |
Why?
|
Mice | 7 | 2023 | 81178 | 0.080 |
Why?
|
tau Proteins | 1 | 2018 | 1868 | 0.080 |
Why?
|
Radiographic Image Enhancement | 1 | 2013 | 885 | 0.080 |
Why?
|
Odds Ratio | 5 | 2022 | 9849 | 0.080 |
Why?
|
Lead | 1 | 2013 | 854 | 0.080 |
Why?
|
Child | 13 | 2023 | 77679 | 0.080 |
Why?
|
CpG Islands | 2 | 2023 | 1172 | 0.080 |
Why?
|
Microsatellite Repeats | 2 | 2006 | 802 | 0.080 |
Why?
|
Blood Vessels | 1 | 2013 | 1126 | 0.070 |
Why?
|
Tobacco Smoke Pollution | 2 | 2011 | 815 | 0.070 |
Why?
|
Gene Order | 1 | 2007 | 176 | 0.070 |
Why?
|
Prevalence | 4 | 2020 | 15226 | 0.070 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2007 | 88 | 0.070 |
Why?
|
Elastin | 1 | 2008 | 308 | 0.070 |
Why?
|
Animals | 8 | 2023 | 168788 | 0.070 |
Why?
|
Societies, Medical | 1 | 2019 | 3741 | 0.070 |
Why?
|
Protein Isoforms | 2 | 2021 | 1731 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2017 | 19907 | 0.070 |
Why?
|
Latent TGF-beta Binding Proteins | 1 | 2006 | 42 | 0.070 |
Why?
|
Genetic Heterogeneity | 1 | 2010 | 733 | 0.070 |
Why?
|
Pulmonary Artery | 1 | 2015 | 1912 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2017 | 3085 | 0.070 |
Why?
|
Age Factors | 3 | 2021 | 18367 | 0.070 |
Why?
|
ADAM Proteins | 1 | 2007 | 243 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2020 | 3690 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2017 | 3278 | 0.070 |
Why?
|
Boston | 5 | 2021 | 9311 | 0.060 |
Why?
|
Airway Obstruction | 1 | 2010 | 663 | 0.060 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2006 | 462 | 0.060 |
Why?
|
Tobacco Use Disorder | 1 | 2011 | 688 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3747 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2021 | 77426 | 0.060 |
Why?
|
Epoxy Compounds | 1 | 2005 | 136 | 0.060 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2005 | 171 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9147 | 0.060 |
Why?
|
Treatment Outcome | 7 | 2021 | 63119 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2022 | 3921 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3086 | 0.060 |
Why?
|
Mixed Function Oxygenases | 1 | 2005 | 272 | 0.060 |
Why?
|
Radiography | 2 | 2014 | 7022 | 0.060 |
Why?
|
Family Health | 2 | 2006 | 1282 | 0.060 |
Why?
|
Proteins | 1 | 2018 | 6101 | 0.060 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 21824 | 0.060 |
Why?
|
Thoracoscopes | 1 | 2002 | 3 | 0.060 |
Why?
|
Epigenomics | 2 | 2019 | 903 | 0.060 |
Why?
|
Siblings | 1 | 2007 | 854 | 0.060 |
Why?
|
Morbidity | 2 | 2022 | 1769 | 0.060 |
Why?
|
Drug Therapy, Combination | 3 | 2021 | 6485 | 0.060 |
Why?
|
Adiponectin | 2 | 2019 | 1100 | 0.060 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2005 | 799 | 0.050 |
Why?
|
Hypertension, Pulmonary | 2 | 2015 | 1536 | 0.050 |
Why?
|
Oximetry | 2 | 2016 | 469 | 0.050 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 2021 | 49 | 0.050 |
Why?
|
Carcinoma, Bronchogenic | 1 | 2001 | 87 | 0.050 |
Why?
|
HLA Antigens | 1 | 2007 | 1382 | 0.050 |
Why?
|
Punctures | 1 | 2003 | 374 | 0.050 |
Why?
|
Pleural Diseases | 1 | 2002 | 139 | 0.050 |
Why?
|
GTPase-Activating Proteins | 2 | 2015 | 498 | 0.050 |
Why?
|
Cloning, Molecular | 1 | 2007 | 4321 | 0.050 |
Why?
|
Niacinamide | 1 | 2023 | 416 | 0.050 |
Why?
|
Codon, Terminator | 1 | 2021 | 127 | 0.050 |
Why?
|
Promoter Regions, Genetic | 3 | 2011 | 5867 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2007 | 1366 | 0.050 |
Why?
|
Myosins | 1 | 2022 | 409 | 0.050 |
Why?
|
Observer Variation | 1 | 2007 | 2593 | 0.050 |
Why?
|
Genes, Switch | 1 | 2020 | 47 | 0.050 |
Why?
|
Surgical Instruments | 1 | 2003 | 395 | 0.050 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 314 | 0.040 |
Why?
|
Arylsulfotransferase | 1 | 2019 | 28 | 0.040 |
Why?
|
rab4 GTP-Binding Proteins | 1 | 2019 | 7 | 0.040 |
Why?
|
Hand Strength | 1 | 2022 | 448 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 513 | 0.040 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 437 | 0.040 |
Why?
|
Colletotrichum | 1 | 2018 | 1 | 0.040 |
Why?
|
Adolescent | 6 | 2021 | 85759 | 0.040 |
Why?
|
Weight Loss | 2 | 2021 | 2622 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2013 | 4041 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2012 | 4419 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 7908 | 0.040 |
Why?
|
Bronchi | 2 | 2013 | 840 | 0.040 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2019 | 257 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2006 | 2008 | 0.040 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2023 | 838 | 0.040 |
Why?
|
Muscles | 1 | 2022 | 1622 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15161 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 743 | 0.040 |
Why?
|
Cough | 2 | 2013 | 555 | 0.040 |
Why?
|
Receptors, Leptin | 1 | 2018 | 360 | 0.040 |
Why?
|
C-Peptide | 1 | 2018 | 419 | 0.040 |
Why?
|
Family | 3 | 2017 | 3148 | 0.040 |
Why?
|
Body Composition | 2 | 2017 | 2400 | 0.040 |
Why?
|
Sarcoglycans | 1 | 2015 | 55 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 671 | 0.030 |
Why?
|
Sample Size | 1 | 2019 | 846 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2916 | 0.030 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2015 | 58 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2023 | 13036 | 0.030 |
Why?
|
Young Adult | 5 | 2021 | 56436 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2018 | 1202 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2017 | 365 | 0.030 |
Why?
|
New Zealand | 1 | 2015 | 357 | 0.030 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2015 | 150 | 0.030 |
Why?
|
Bronchitis | 1 | 2015 | 201 | 0.030 |
Why?
|
Hospitalization | 1 | 2014 | 10262 | 0.030 |
Why?
|
Hepatocytes | 1 | 2021 | 1210 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 11732 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2540 | 0.030 |
Why?
|
Massachusetts | 1 | 2007 | 8663 | 0.030 |
Why?
|
Total Lung Capacity | 1 | 2014 | 143 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2022 | 1194 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1071 | 0.030 |
Why?
|
ABO Blood-Group System | 1 | 2016 | 367 | 0.030 |
Why?
|
Mutation | 3 | 2023 | 29784 | 0.030 |
Why?
|
Incidence | 4 | 2018 | 20945 | 0.030 |
Why?
|
Serpins | 1 | 2015 | 247 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3527 | 0.030 |
Why?
|
Electric Impedance | 1 | 2017 | 729 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7281 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15999 | 0.030 |
Why?
|
Computer Simulation | 2 | 2017 | 6196 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2309 | 0.030 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2014 | 417 | 0.030 |
Why?
|
Reference Standards | 1 | 2017 | 1025 | 0.030 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2013 | 144 | 0.030 |
Why?
|
Mental Status Schedule | 1 | 2013 | 321 | 0.030 |
Why?
|
Lung Transplantation | 1 | 2001 | 1155 | 0.030 |
Why?
|
Heart Failure | 1 | 2016 | 10905 | 0.030 |
Why?
|
Metabolome | 1 | 2019 | 895 | 0.030 |
Why?
|
Down-Regulation | 1 | 2020 | 3001 | 0.030 |
Why?
|
Regeneration | 1 | 2021 | 1485 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12355 | 0.030 |
Why?
|
Gestational Age | 1 | 2021 | 3493 | 0.030 |
Why?
|
Sp3 Transcription Factor | 1 | 2011 | 29 | 0.030 |
Why?
|
Bronchospirometry | 1 | 2011 | 10 | 0.030 |
Why?
|
Tomography, Spiral Computed | 1 | 2013 | 280 | 0.030 |
Why?
|
Internationality | 1 | 2017 | 1003 | 0.030 |
Why?
|
Poland | 1 | 2012 | 184 | 0.030 |
Why?
|
Demography | 1 | 2017 | 1656 | 0.030 |
Why?
|
Valine | 1 | 2013 | 413 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2021 | 19227 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2011 | 300 | 0.020 |
Why?
|
Sex Factors | 2 | 2016 | 10396 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1838 | 0.020 |
Why?
|
Leptin | 1 | 2018 | 1599 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2013 | 528 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2012 | 690 | 0.020 |
Why?
|
Bone Density | 1 | 2022 | 3468 | 0.020 |
Why?
|
Cell Cycle | 1 | 2017 | 2967 | 0.020 |
Why?
|
Fibrinogen | 1 | 2012 | 894 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5076 | 0.020 |
Why?
|
Online Systems | 1 | 2009 | 184 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2019 | 2715 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 893 | 0.020 |
Why?
|
Gastroesophageal Reflux | 1 | 2016 | 782 | 0.020 |
Why?
|
Regression Analysis | 2 | 2009 | 6461 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 40992 | 0.020 |
Why?
|
Extracellular Matrix Proteins | 1 | 2013 | 849 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2001 | 4151 | 0.020 |
Why?
|
Health Services | 1 | 2013 | 758 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1655 | 0.020 |
Why?
|
Monocytes | 1 | 2017 | 2594 | 0.020 |
Why?
|
Angiography | 1 | 2013 | 1638 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2864 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3558 | 0.020 |
Why?
|
Hypercapnia | 1 | 2008 | 260 | 0.020 |
Why?
|
Walking | 1 | 2014 | 1180 | 0.020 |
Why?
|
Bronchoconstrictor Agents | 1 | 2006 | 77 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5657 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3646 | 0.020 |
Why?
|
Methacholine Chloride | 1 | 2006 | 233 | 0.020 |
Why?
|
Vitamin D | 1 | 2020 | 3222 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14556 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 1183 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7730 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4935 | 0.020 |
Why?
|
Liver | 1 | 2021 | 7472 | 0.020 |
Why?
|
Reference Values | 1 | 2013 | 4982 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8090 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3508 | 0.020 |
Why?
|
Haplotypes | 1 | 2011 | 2781 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2848 | 0.020 |
Why?
|
Neutrophils | 1 | 2017 | 3717 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1677 | 0.020 |
Why?
|
Genetics, Population | 1 | 2009 | 934 | 0.020 |
Why?
|
Time Factors | 2 | 2018 | 40063 | 0.020 |
Why?
|
International Cooperation | 1 | 2011 | 1421 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3509 | 0.020 |
Why?
|
Blood Glucose | 1 | 2018 | 6259 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10182 | 0.010 |
Why?
|
Acute Disease | 1 | 2014 | 7148 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5180 | 0.010 |
Why?
|
Insulin | 1 | 2018 | 6583 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4217 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3505 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12781 | 0.010 |
Why?
|
Occupational Exposure | 1 | 2013 | 1796 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2001 | 5221 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2012 | 3201 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16687 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6367 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9582 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 25618 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2007 | 1725 | 0.010 |
Why?
|
Veterans | 1 | 2013 | 2519 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2005 | 2970 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 8950 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10480 | 0.010 |
Why?
|
Biomedical Research | 1 | 2011 | 3311 | 0.010 |
Why?
|
Equipment Design | 1 | 2002 | 3582 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20817 | 0.010 |
Why?
|
Aging | 1 | 2010 | 8661 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2001 | 11007 | 0.000 |
Why?
|